![]() Biond Biologics Biond Biologics is a company developing immunotherapies for cancer and autoimmune diseases. | ![]() Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | ![]() Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ![]() Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. | |
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2002 | Founding Date 2016 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Nahariya, IL HQ | Locations Lexington, US HQ South Wharf, AU | Locations København, DK HQ Cary, US Cary, US | Locations Oxford, GB HQ |
Employees | Employees 40 | Employees 7854% decrease | Employees 54 | Employees 452% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $244.1m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A |
Net income | Net income N/A | Net income $87m (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 17m | Total funding raised $ 90m | Total funding raised $ 60m | Total funding raised $ 158.6m |

Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
View company